“…Combined hepatorenal transplantation should be considered as the first therapeutic option for patients with ESRD because of (i) the frequent recurrences of AFib amyloidosis on renal transplants, then premature transplant losses, (ii) the relatively early onset of AFib amyloidosisrelated ESRD, and (iii) the risk of systemic evolution of the disease. Thirteen cases of hepatorenal transplantation have been reported [3,4,8,9]. In the largest cohort, six of nine patients (66%) are alive with good liver and renal functions without recurrence [4].…”